John T Curnutte insider trades

Open-market stock purchases and sales by John T Curnutte, Director at Pliant Therapeutics, Inc, from SEC Form 4 filings since Mar 26, 2014.

Recent trades

DateStockTradeValue
Jun 11, 2026PLRX Pliant Therapeutics, IncBought (not open market)—

Companies traded

  • PLRX Pliant Therapeutics, Inc: other filings, last Jun 11, 2026
  • ORTX Orchard Therapeutics plc: other filings, last Jan 24, 2024
  • PTLA Portola Pharmaceuticals Inc: 20 sales, last May 20, 2019
  • DDXS Diadexus, Inc: other filings, last Jul 15, 2015

Get free alerts when John T Curnutte files a new trade →